1. Critique of the analysis of the time course for the antimigraine effect of ubrogepant 50 mg. Clinical relevance versus statistical significance. (October 2021) Authors: Tfelt-Hansen, Peer; Hüsing, Anika; Diener, Hans-Christoph Journal: Cephalalgia Issue: Volume 41:Number 11/12(2021) Page Start: 1276 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Doubtful use of placebo following placebo in recent controlled trials of lasmiditan and ubrogepant for the treatment of migraine attacks. (January 2022) Authors: Tfelt-Hansen, Peer; Jørgensen, Karsten; Diener, Hans-Christoph Journal: Cephalalgia Issue: Volume 42:Number 1(2022) Page Start: 82 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Erenumab prevents the occurrence of migraine attacks and not just migraine days: Post-hoc analyses of a phase III study. (October 2021) Authors: Diener, Hans-Christoph; Ashina, Messoud; Ritter, Shannon; Paiva Da Silva Lima, Gabriel; Rasmussen, Soeren; Zielman, Ronald; Tfelt-Hansen, Peer Journal: Cephalalgia Issue: Volume 41:Number 11/12(2021) Page Start: 1262 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Evaluating the reporting of adverse events in controlled clinical trials conducted in 2010–2015 on migraine drug treatments. (October 2018) Authors: Tfelt-Hansen, Peer; Lindqvist, Janus Kaufmann; Do, Thien Phu Journal: Cephalalgia Issue: Volume 38:Number 12(2018) Page Start: 1885 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. General lack of use of placebo in prophylactic, randomised, controlled trials in adult migraine. A systematic review. (September 2016) Authors: Hougaard, Anders; Tfelt-Hansen, Peer Journal: Cephalalgia Issue: Volume 36:Number 10(2016) Page Start: 960 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Imprecise diagnosis of migraine with aura in the Women's Health Study. Does it matter?. (June 2014) Authors: Tfelt-Hansen, Peer Journal: Cephalalgia Issue: Volume 34:Number 7(2014) Page Start: 559 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Increase in self-reported migraine prevalence in the Danish adult population: a prospective longitudinal population-based study. Issue 4 (2nd July 2012) Authors: Le, Han; Tfelt-Hansen, Peer; Skytthe, Axel; Kyvik, Kirsten Ohm; Olesen, Jes Journal: BMJ open Issue: Volume 2:Issue 4(2012) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Meralgia Paresthetica after Prone Positioning Ventilation in the Intensive Care Unit. (26th September 2016) Authors: Juhl, Christian Svendsen; Ballegaard, Martin; Bestle, Morten H.; Tfelt-Hansen, Peer Other Names: Molnar Zsolt Academic Editor. Journal: Case reports in critical care Issue: Volume 2016(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Naratriptan is as effective as sumatriptan for the treatment of migraine attacks when used properly. A mini-review. (December 2021) Authors: Tfelt-Hansen, Peer Journal: Cephalalgia Issue: Volume 41:Number 14(2021) Page Start: 1499 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Only 4.9% (24/494) of original papers on migraine and headache published in Cephalalgia 2014–2018 concerned actual spontaneous or provoked migraine/headache attacks: A comment. (26th November 2019) Authors: Tfelt-Hansen, Peer Journal: Cephalalgia reports Issue: Volume 2(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗